全文获取类型
收费全文 | 1104篇 |
免费 | 103篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 47篇 |
妇产科学 | 23篇 |
基础医学 | 181篇 |
口腔科学 | 28篇 |
临床医学 | 201篇 |
内科学 | 192篇 |
皮肤病学 | 22篇 |
神经病学 | 72篇 |
特种医学 | 20篇 |
外科学 | 80篇 |
一般理论 | 1篇 |
预防医学 | 100篇 |
眼科学 | 43篇 |
药学 | 93篇 |
肿瘤学 | 84篇 |
出版年
2024年 | 1篇 |
2023年 | 9篇 |
2022年 | 13篇 |
2021年 | 23篇 |
2020年 | 17篇 |
2019年 | 40篇 |
2018年 | 33篇 |
2017年 | 39篇 |
2016年 | 32篇 |
2015年 | 28篇 |
2014年 | 46篇 |
2013年 | 70篇 |
2012年 | 64篇 |
2011年 | 63篇 |
2010年 | 34篇 |
2009年 | 53篇 |
2008年 | 60篇 |
2007年 | 57篇 |
2006年 | 55篇 |
2005年 | 66篇 |
2004年 | 61篇 |
2003年 | 48篇 |
2002年 | 57篇 |
2001年 | 14篇 |
2000年 | 8篇 |
1999年 | 10篇 |
1998年 | 15篇 |
1997年 | 14篇 |
1996年 | 14篇 |
1995年 | 14篇 |
1994年 | 7篇 |
1993年 | 8篇 |
1992年 | 12篇 |
1991年 | 13篇 |
1990年 | 9篇 |
1989年 | 12篇 |
1988年 | 12篇 |
1987年 | 9篇 |
1986年 | 13篇 |
1985年 | 28篇 |
1984年 | 12篇 |
1983年 | 6篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 4篇 |
1979年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1967年 | 1篇 |
1962年 | 1篇 |
排序方式: 共有1210条查询结果,搜索用时 46 毫秒
41.
Hämäläinen A Pihlajamäki M Tanila H Hänninen T Niskanen E Tervo S Karjalainen PA Vanninen RL Soininen H 《Neurobiology of aging》2007,28(12):1889-1903
Structural and functional magnetic resonance imaging (fMRI) was performed on 21 healthy elderly controls, 14 subjects with mild cognitive impairment (MCI) and 15 patients with mild Alzheimer's disease (AD) to investigate changes in fMRI activation in relation to underlying structural atrophy. The fMRI paradigm consisted of associative encoding of novel picture-word pairs. Structural analysis of the brain was performed using voxel-based morphometry (VBM) and hippocampal volumetry. Compared to controls, the MCI subjects exhibited increased fMRI responses in the posterior hippocampal, parahippocampal and fusiform regions, while VBM revealed more atrophy in MCI in the anterior parts of the left hippocampus. Furthermore, the hippocampal volume and parahippocampal activation were negatively correlated in MCI, but not in controls or in AD. We suggest that the increased fMRI activation in MCI in the posterior medial temporal and closely connected fusiform regions is compensatory due to the incipient atrophy in the anterior medial temporal lobe. 相似文献
42.
43.
Bruehl S al'Absi M France CR France J Harju A Burns JW Chung OY 《Journal of behavioral medicine》2007,30(3):209-219
This study explored possible gender moderation of previously reported associations between elevated trait anger-out and reduced
endogenous opioid analgesia. One hundred forty-five healthy participants underwent acute electrocutaneous pain stimulation
after placebo and oral opioid blockade in separate sessions. Blockade effects were derived reflecting changes in pain responses
induced by opioid blockade. Hierarchical regressions revealed that elevated anger-out was associated with smaller pain threshold
blockade effects (less opioid analgesia) in females, with opposite findings in males (interaction p < .001). Similar marginally significant interactions were noted for blockade effects derived for nociceptive flexion reflex
threshold, pain tolerance, and pain ratings (p < .10). Anger-in was also associated negatively with pain threshold blockade effects in females but not males (interaction
p < .05). Across genders, elevated anger-in was related to smaller pain tolerance blockade effects (p < .01). Overlap with negative affect did not account for these opioid effects. The anger-in/opioid association was partially
due to overlap with anger-out, but the converse was not true. These findings provide additional evidence of an association
between trait anger-out and endogenous opioid analgesia, but further suggest that gender may moderate these effects. In contrast
to past work, anger-in was related to reduced opioid analgesia, although overlap with anger-out may contribute to this finding. 相似文献
44.
45.
Gearoid M. McMahon Matthias Olden Maija Garnaas Qiong Yang Xuan Liu Shih-Jen Hwang Martin G. Larson CKDGen Consortium Wolfram Goessling Caroline S. Fox 《Journal of the American Society of Nephrology : JASN》2014,25(12):2896-2905
Novel biomarkers are being investigated to identify patients with kidney disease. We measured a panel of 13 urinary biomarkers in participants from the Offspring Cohort of the Framingham Heart Study. Using an Affymetrix chip with imputation to 2.5 M single-nucleotide polymorphisms (SNPs), we conducted a GWAS of these biomarkers (n=2640) followed by exonic sequencing and genotyping. Functional studies in zebrafish were used to investigate histologic correlation with renal function. Across all 13 biomarkers, there were 97 significant SNPs at three loci. Lead SNPs at each locus were rs6555820 (P=6.7×10−49; minor allele frequency [MAF]=0.49) in HAVCR1 (associated with kidney injury molecule-1), rs7565788 (P=2.15×10−16; MAF=0.22) in LRP2 (associated with trefoil factor 3 [TFF3]), and rs11048230 (P=4.77×10−8; MAF=0.10) in an intergenic region near RASSF8 (associated with vascular endothelial growth factor). Validation in the CKDGen Consortium (n=67,093) showed that only rs7565788 at LRP2, which encodes megalin, was associated with eGFR (P=0.003). Sequencing of exons 16–72 of LRP2 in 200 unrelated individuals at extremes of urinary TFF3 levels identified 197 variants (152 rare; MAF<0.05), 31 of which (27 rare) were nonsynonymous. In aggregate testing, rare variants were associated with urinary TFF3 levels (P=0.003), and the lead GWAS signal was not explained by these variants. Knockdown of LRP2 in zebrafish did not alter the renal phenotype in static or kidney injury models. In conclusion, this study revealed common variants associated with urinary levels of TFF3, kidney injury molecule-1, and vascular endothelial growth factor and identified a cluster of rare variants independently associated with TFF3.Serum creatinine, as used in most GFR estimating equations, is the primary biomarker of CKD.1 Creatinine has significant limitations as a biomarker. It is insensitive to early declines in kidney function, and there are important extrarenal factors that influence its concentration, thus increasing the potential for misclassification when it is used to diagnose renal disease.2 As a result, novel biomarkers are being investigated that could allow earlier and more accurate diagnosis of CKD.3 It is likely, however, that these biomarkers also have non-GFR determinants, including genetic factors. For example, levels of cystatin C, a novel GFR biomarker, are known to be influenced by both nongenetic factors, such as adiposity and the metabolic syndrome,4 and the presence of specific genetic variants in the cystatin C-gene cluster.5Genome-wide association studies (GWAS) allow for the evaluation of genetic associations of biomarkers in an unbiased manner. These studies could illuminate previously unrecognized pathways for CKD pathogenesis, thus identifying new potential molecular targets for therapeutic intervention. Multiple variants have been identified in association with kidney function through GWAS,6 whereas a variant in CUBN encoding cubilin, a proximal tubular transport protein, has been associated with albuminuria.7 Recently, a GWAS identified a locus at PTGDS in association with another kidney biomarker, β-trace protein.8To gain additional insight into biologic pathways of renal function and kidney injury, we measured a panel of 13 urinary biomarkers in participants from the Framingham Heart Study (FHS) and performed a GWAS of their levels. Here, we report the primary results from these studies as well as follow-up work to identify whether rare variants in LRP2 are associated with levels of trefoil factor 3 (TFF3). 相似文献
46.
47.
Anne Raben PhD Pia Siig Vestentoft PhD Jennie Brand-Miller PhD Elli Jalo MSc Mathjis Drummen PhD Liz Simpson PhD J. Alfredo Martinez PhD Teodora Handjieva-Darlenska PhD Gareth Stratton PhD Maija Huttunen-Lenz PhD Tony Lam MBA Jouko Sundvall MSc Roslyn Muirhead PhD Sally Poppitt PhD Christian Ritz PhD Kirsi H. Pietiläinen PhD Margriet Westerterp-Plantenga PhD Moira A. Taylor PhD Santiago Navas-Carretero PhD Svetoslav Handjiev PhD Melitta A. McNarry PhD Sylvia Hansen MSc Laura Råman BSc Shannon Brodie MSc Marta P. Silvestre PhD Tanja C. Adam PhD Ian A. Macdonald PhD Rodrigo San-Cristobal PhD Nadka Boyadjieva PhD Kelly A. Mackintosh PhD Wolfgang Schlicht PhD Amy Liu PhD Thomas M. Larsen PhD Mikael Fogelholm DSc 《Diabetes, obesity & metabolism》2021,23(2):324-337
48.
Max J. Åström Mikaela B. von Bonsdorff Maija Haanpää Minna K. Salonen Hannu Kautiainen Johan G. Eriksson 《Primary Care Diabetes》2021,15(3):561-566
AimsTo assess if individuals with diabetes or prediabetes report more pain or have increased use of pain medication compared to normoglycaemic individuals.MethodsUsing cross-sectional data, we studied 928 men and 1075 women from the Helsinki Birth Cohort Study in 2001–2004 at a mean age of 61.5 years. Glucose regulation was assessed with a 2-h 75 g oral glucose tolerance test, and applying World Health Organization criteria, participants were defined as having normoglycaemia, prediabetes (impaired fasting glucose or impaired glucose tolerance), newly diagnosed diabetes or previously diagnosed diabetes. Self-reported pain intensity and interference during the previous 4 weeks was estimated using the RAND 36-Item Health Survey 1.0. Information on use of pain medication during the past 12 months was obtained from the Social Insurance Institution of Finland.ResultsThere was no difference in pain intensity or interference between glucose regulation groups for neither men nor women after adjusting for covariates (age, body mass index, education years, Beck Depression Inventory and physical activity). In addition, use of pain medication was similar between glucose regulation groups.ConclusionsAlthough pain is a common symptom in the general population, impairments in glucose regulation alone does not seem to increase pain among older individuals. 相似文献
49.
Ushanandini Mohanraj Maija Jokinen Rajita Rayamajhi Thapa Minna Paloniemi Timo Vesikari Maija Lappalainen Eveliina Tarkka Zaiga Nora-Krkle Anda Vilmane Kim Vettenranta Charles Mangani Sami Oikarinen Yue-Mei Fan Per Ashorn Elina Visnen Maria Sderlund-Venermo 《Viruses》2021,13(3)
Three human protoparvoviruses, bufavirus (BuV), tusavirus (TuV) and cutavirus (CuV), have recently been discovered in diarrheal stool. BuV has been associated with diarrhea and CuV with cutaneous T-cell lymphoma, but there are hardly any data for TuV or CuV in stool or respiratory samples. Hence, using qPCR and IgG enzyme immunoassays, we analyzed 1072 stool, 316 respiratory and 445 serum or plasma samples from 1098 patients with and without gastroenteritis (GE) or respiratory-tract infections (RTI) from Finland, Latvia and Malawi. The overall CuV-DNA prevalences in stool samples ranged between 0–6.1% among our six patient cohorts. In Finland, CuV DNA was significantly more prevalent in GE patients above rather than below 60 years of age (5.1% vs 0.2%). CuV DNA was more prevalent in stools among Latvian and Malawian children compared with Finnish children. In 10/11 CuV DNA-positive adults and 4/6 CuV DNA-positive children with GE, no known causal pathogens were detected. Interestingly, for the first time, CuV DNA was observed in two nasopharyngeal aspirates from children with RTI and the rare TuV in diarrheal stools of two adults. Our results provide new insights on the occurrence of human protoparvoviruses in GE and RTI in different countries. 相似文献
50.